Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Targeted therapy for brain cancer shows efficacy

Written by | 10 Jun 2023

In patients diagnosed with grade 2 IDH-mutant glioma, treatment with investigative vorasidenib has significantly improved progression-free survival. The findings were published on June 5, 2023 in the NEJM/New… read more.

Immunotherapy before targeted therapy improves survival in advanced melanoma

Written by | 4 Oct 2022

Researchers reported a 20 percent advantage in the two-year overall survival rate for subjects with advanced melanoma and a mutation in the BRAF gene, specifically a BRAF V600 mutation, who were initially… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.